Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
3(100.0%)
3Total
Phase 3(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03491826Completed

Fetal and Maternal Outcome in Preterm Premature Rupture of Membranes (PPROM)

Role: lead

NCT03473041Phase 3Unknown

Autologous Rectus Sheath Fascia Versus Midurethral Transobturator Tension Free Vaginal

Role: lead

NCT03463863Phase 3Completed

Midurethral Sling With Autologus Rectus Sheath

Role: lead

NCT03463070Phase 3Unknown

Misoprostol Before and After Cesarean Section

Role: lead

All 4 trials loaded